Cancer BiologyCell Reports MedicinePeer-reviewed
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or‐Yam Revach, Angelina M. Cicerchia, Ofir Shorer…·Russell William Jenkins
This study shows that targeting CD38 improves T cell function and restores response to immunotherapy in melanoma models.
19 citationstop 2%